ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,840.40
      1.01%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.565
      -0.88%
      Bitcoin
      56,350.90
      -1.10%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Oncodesign Precision Medicine SA (ALOPM) Quote

      Oncodesign Precision Medicine SA

      Oncodesign Precision Medicine SA (ALOPM)

      EU
      1.015
      0.015
      (1.50%)
      Closed July 05 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.015
      Bid
      0.99
      Ask
      1.15
      Volume
      11,083
      0.98 Day's Range 1.015
      0.92 52 Week Range 2.39
      Market Cap
      18.191M
      Previous Close
      1.00
      Open
      1.00
      Last Trade
      70
      @
      1.015
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      10,069
      Shares Outstanding
      18,190,878
      Dividend Yield
      -
      PE Ratio
      -2.27
      Earnings Per Share (EPS)
      -0.44
      Revenue
      1.08M
      Net Profit
      -8.09M

      About Oncodesign Precision Medicine SA

      Sector
      Electromedical Apparatus
      Industry
      Electromedical Apparatus
      Website
      www.oncodesign.com
      Headquarters
      Dijon, Cote-d'or, Fra
      Founded
      1970
      Oncodesign Precision Medicine SA is listed in the Electromedical Apparatus sector of the Euronext with ticker ALOPM. The last closing price for Oncodesign Precision Med... was 1.00 €. Over the last year, Oncodesign Precision Med... shares have traded in a share price range of 0.92 € to 2.39 €.

      Oncodesign Precision Med... currently has 18,190,878 shares outstanding. The market capitalization of Oncodesign Precision Med... is 18.19 € million. Oncodesign Precision Med... has a price to earnings ratio (PE ratio) of -2.27.

      ALOPM Latest News

      More News

      Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

      Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement des cancers...

      5 hours ago
      Business Wire

      Oncodesign Precision Medicine : Apport complémentaire au contrat de liquidité

      Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement...

      June 18 2024
      Business Wire

      OPM met à disposition les informations relatives à l’Assemblée Générale des actionnaires du 26 juin 2024

      Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement des cancers...

      May 22 2024
      Business Wire

      Oncodesign Precision Medicine and Navigo Proteins GmbH Sign a Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents

      Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and...

      May 15 2024
      Business Wire

      OPM met à disposition son rapport financier annuel 2023

      Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement...

      April 25 2024
      Business Wire

      Degroof Petercam initie la couverture d’Oncodesign Precision Medicine

      Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement des cancers...

      April 18 2024
      Business Wire

      Oncodesign Precision Medicine (OPM) obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101

      DEMOCRITE Project: Demonstrating the efficiency of OPM-101 by targeting RIPK2 in Inflammatory Bowel Disease Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic:...

      April 17 2024
      Business Wire

      OPM Publishes Its Annual Results for 2023 and Provides an Update on Its Clinical Developments

      · R&D investment up 27% to €8.8 M, mainly linked to the clinical development of OPM-101 and the start of a preclinical program in oncology OPM-102 Cash position of €10 M on December the 31st...

      March 26 2024
      Business Wire

      Oncodesign Precision Medicine obtient un financement d’Aide au Développement Deep Tech pour son programme ANIMUS

      Programme ANIMUS : développement de méthodes propriétaires utilisant l’IA pour l’optimisation des molécules issues de notre technologie Nanocyclix®, pour sélectionner plus rapidement des...

      February 29 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.010.9950248756221.0051.040.9268810.95347272DE
      4-0.21-17.14285714291.2251.2250.92112561.05289362DE
      12-0.545-34.93589743591.561.60.92100691.24500921DE
      26-0.855-45.72192513371.872.060.92120191.36013979DE
      52-0.31-23.39622641511.3252.390.92109491.61748373DE
      1560.0252.525252525250.992.390.85106151.56027201DE
      2600.0252.525252525250.992.390.85106151.56027201DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DYNTDynatronics Corp
      $ 0.3849
      (81.56%)
      		2.54M
      SHPWShapeways Holdings Inc
      $ 0.33
      (57.14%)
      		257.95k
      CNFRConifer Holdings Inc
      $ 0.8835
      (13.25%)
      		200
      IVPInspire Veterinary Partners Inc
      $ 1.65
      (10.74%)
      		147.48k
      YOSHYoshiharu Global Company
      $ 4.55
      (10.17%)
      		581
      ABTSAbits Group Ltd
      $ 0.42
      (-12.80%)
      		3.89k
      SNOASonoma Pharmaceuticals Inc
      $ 0.3285
      (-8.72%)
      		94.44k
      STSSSharps Technology Inc
      $ 0.2371
      (-8.42%)
      		103.52k
      FBIOFortress Biotech Inc
      $ 1.68
      (-7.18%)
      		2.75k
      ALBTAvalon GloboCare Corporation
      $ 0.496
      (-6.89%)
      		196
      MAXNMaxeon Solar Technologies Ltd
      $ 0.248
      (4.29%)
      		8.07M
      WBDWarner Brothers Discovery Inc
      $ 7.21
      (-0.07%)
      		5.95M
      NVDANVIDIA Corporation
      $ 125.78
      (-0.03%)
      		3.04M
      DYNTDynatronics Corp
      $ 0.3849
      (81.56%)
      		2.54M
      HSTHost Hotels and Resorts Inc
      $ 17.48
      (-0.06%)
      		1.67M

      Discussion

      View Full Feed
      Chart Reader Chart Reader 1 minute ago
      Are we talking about making money or analyzing what AI means fundamentally to humanity? I ask this because this board and this site is supposed to be about "investing" and not about analyzing the fundamental future of humanity. If AI does take control of us, making or losing money will be the least
      SNOW
      MartinLutherKing MartinLutherKing 1 minute ago
      Next week is ours brothers GLTA Brothers
      RNAZ
      I-Glow I-Glow 1 minute ago
      Then prove what I posted isn't accurate - another bottom feeding pumper that never posts any research or real DD.

      "Complete lies... First it was never coming out. Now this.

      Lies. Very odd indeed that you can't find what you're looking for."

      The little pum
      SPZI
      LakeshoreLeo1953 LakeshoreLeo1953 2 minutes ago
      Anonymity is a fool’s cloak
      AVXL
      kbaz kbaz 2 minutes ago
      Law and Order in the US has been Replaced by a non Elected Oligarchy that has lead to a Govt that uses these Organizations to Enrich themselves as opposed to Policing for All.... This is What Happens when a Population would rather be told that They need to be on the Correct Side of Made up Social
      SFIO
      BIOChecker4 BIOChecker4 2 minutes ago
      Blah, blah, blah. I still own shares. You’re free to choose to believe whatever fantasy you wish to believe. I’ve explained my position several times in the past. If you had read my posts, you’d know it already. Missling is the CEO. He runs the show. He has no credibility with big money biotech inst
      AVXL
      JJ8 JJ8 3 minutes ago
      Bull!
      NVDA
      Zilla Zilla 3 minutes ago
      Friday after the 4th of July BHC closed at 7.23 with a range of 6.99 - 7.27 and 2.6 million shares traded...
      200DMA 7.86
      50DMA 6.97
      20DMA 6,83
      Really nice trading range and 50DMA should start heading up soon. I expect a couple days red (after 6 black days) but the way it
      BHC
      Talon38 Talon38 4 minutes ago
      Ziggy, I'm sorry, your pessimism has been present well before the end of this week...I must give credit were credit is due! Have a nice weekend....I don't mean to spoil it before it has begun.
      AVXL
      arizona1 arizona1 4 minutes ago
      NY Times publishes op-ed urging people not to vote, changes title, then removes it from front page

      If you perused the face page of the New York Times’ website this morning, you would have seen an op-ed piece, characterized as a “guest essay,” by a right winger named Matthew Walther ti
      cowtown jay cowtown jay 4 minutes ago
      The Mayo Clinic case-cohort study, and Humanigen's LIVE-AIR trial, both showed durable, repeatable, safety and efficacy in patient treatment outcomes before there were vaccines. The vaccines only increased the number of patients who will subsequently need lenz.
      HGENQ
      jay_tee jay_tee 4 minutes ago
      Monday after next
      RNVA
      PioneerCorsair42 PioneerCorsair42 5 minutes ago
      Down on the day after YUGE news! Pumpturds didn’t get the buy volume they were hoping for to unload into is my take. What’s the next YUGE news gonna be? Market was meh on this one!
      SPZI
      2020trader 2020trader 5 minutes ago
      we are all waiting
      CLNV
      tmcfo tmcfo 5 minutes ago
      Reality is that they have been consistently inconsistent so , again, I wouldn't be surprised if they, out of the blue, would make announcement about a new contract and uplisting. The Jv announcement was came out of nowhere and was not anticipated.
      MVNT
      Risk vs Reward Risk vs Reward 5 minutes ago
      All good just asking….
      KULR
      2020trader 2020trader 6 minutes ago
      wasted time and money...big mistake by mgt - imo
      CLNV
      Monksdream Monksdream 6 minutes ago
      INTERESTING mix of Gsucho Session stocks
      https://ih.advfn.com/markets/nasdaq/afterhours
      govprs govprs 6 minutes ago
      Nobody selling at this level

      I do expect some selling to show up in the 3s since plenty of shares traded below.015

      Foolish to sell in the 3s imho.

      I like this predictions of $1 by end of August. Any progress towards a buck would be welcome
      GDVM
      Kool Aid Man Kool Aid Man 6 minutes ago
      "Awwww-dit" fizzled. So much for the "to da moon" promises that it would generate.

      Park now has his green light to upload all his multi-million/ billion dollar 'assets' into this shell. He can do so at any time. No need to wait till the Q2 deadline on August 15th!
      SPZI
      OzzyS85 OzzyS85 6 minutes ago
      I'm honestly disappointed in more convertibles at .002. I thought we were past that. I imagine the Ceo will pay them off though because there hasn't been dilution here for awhile.
      SMCE
      dannyzee84 dannyzee84 6 minutes ago
      260s next week then we see TSLA sell off as the gamma play will end when the monthly call options expire — jmo
      TSLA
      ksquared ksquared 6 minutes ago
      These demorrhoid cheeseheads don't seem too bright...
      As Biden rallies in Wisconsin, Democratic voters want to evaluate him for themselves
      WILL MCDUFFIE Fri, July 5, 2024 at 3:39 PM EDT·3 min read
      https://news.yahoo.com/news/biden-rallies-wisconsin-democrati
      I-Glow I-Glow 6 minutes ago
      It is listed as a Shell Risk.

      Park signed the 2023 Annual Report as the CEO.

      "It is in all audits of an empty shell which is what this was before park took it over. And it’s now proven to be a clean shell as previously discussed."

      What has Park added to t
      SPZI
      tdbowieknife tdbowieknife 6 minutes ago
      Who you yelling at?


      ..


      .

      Your Recent History

      EU
      ALOPM
      Oncodesign Precision Med...
      NYSE
      DSX
      Diana Shipping
      Delayed Upgrade Clock